Now Diagnostics

NowDx Countersues OraSure in Ongoing Legal Battle Over Point-of-Care Trade Secrets

Following OraSure's November 2024 lawsuit accusing NowDx of misappropriating trade secrets, NowDx has countersued OraSure over similar allegations.

FDA Grants Emergency Use Authorizations for SARS-CoV-2 Tests From Harvard, NowDiagnostics

Harvard's RT-PCR-based test can be used with self-collected nasal samples, while NowDiagnostics' immunoassay can be used with fingerstick blood samples.

Now Diagnostics

NowDx Countersues OraSure in Ongoing Legal Battle Over Point-of-Care Trade Secrets

FDA Grants Emergency Use Authorizations for SARS-CoV-2 Tests From Harvard, NowDiagnostics

Cepheid to Lay off 167 Employees

GenScript Licenses Broad Institute Prime Editing Tech

Judge Denies Qiagen's Motion to Dismiss Zymo Research's Antitrust Suit

Pediatric Brain Cancer Study Yields Prognostic Clues Tied to T-Cell Receptor Features

InformedDNA Acquires Coriell Life Sciences, Adds PGx Capabilities